Skip to main content
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: J Nucl Med. 2007 May 15;48(6):920–925. doi: 10.2967/jnumed.106.037382

FIGURE 1.

FIGURE 1

Coronal and sagittal 18F-FDG PET images of same patient before treatment (A) and after neoadjuvant chemotherapy including granulocyte CSF (B). Right breast cancer decreased in 18F-FDG activity after treatment (arrowheads), whereas 18F-FDG activity increased in marrow in spine, sternum, and ribs (open arrows).